华领医药-B(02552)：张耀樑获委任为薪酬委员会成员

Core Viewpoint - Hualing Pharmaceutical-B (02552) announced the appointment of independent non-executive director Mr. Zhang Yaoliang as a member of the remuneration committee, effective from November 27, 2025. His other positions on the board will remain unchanged [1] Company Summary - The company has made a governance change by appointing Mr. Zhang Yaoliang to the remuneration committee, indicating a focus on enhancing its board structure and oversight [1] - Mr. Zhang will continue to hold his existing roles within the board, suggesting stability in the company's leadership during this transition [1]